Researcher Profile
Researcher Profile
Dawit Aregawi, MD
Assistant Professor, Department of Neurosurgery
Scientific Program:Experimental Therapeutics
Disease Teams:
Central Nervous System Cancer
Research Interests
- Therapeutics
- Polycystic Ovary Syndrome
- Diet
- Metformin
- Glioblastoma
- Neoplasm Metastasis
- Pseudotumor Cerebri
- Neoplasms
- Glioma
- Mutation
- Thrombophilia
- Drug Therapy
Clinical Trials
A Phase 1b/2 study to assess the safety, tolerability and efficacy of BGB-290 in combination with radiation therapy and/or temozolomide in subjects with first-line or recurrent/refractory glioblastoma
Risk Factors for CIPN Following an Oxaliplatin-Containing Chemotherapy Regimen in Colorectal Cancer Patients
A Multicenter Study of 5-Aminolevulinic Acid (5-ALA) to Enhance Visualization of Malignant Tumor in Patients With Newly Diagnosed or Recurrent Malignant Gliomas: A Safety, Histopathology, and Correlative Biomarker Study
Recent Publications
2019
[C@167d9696
[C@1b4fbc92
2017
Davis, G, Lee, M, Aregawi, D, Shaffrey, ME, Schiff, D & Sherman, JH 2017, Spinal metastasis as complication of systemic cancers. in Cancer Neurology in Clinical Practice: Neurological Complications of Cancer and its Treatment: Third Edition. Springer International Publishing, pp. 113-125. https://doi.org/10.1007/978-3-319-57901-6_6
2015
Odia, Y, Kreisl, TN, Aregawi, D, Innis, EK & Fine, HA 2015, 'A phase II trial of tamoxifen and bortezomib in patients with recurrent malignant gliomas', Journal of neuro-oncology, vol. 125, no. 1, pp. 191-195. https://doi.org/10.1007/s11060-015-1894-y